Clinical experience on the use of perampanel in epilepsy among child neurologists in the Philippines

Perampanel is the latest anti-seizure medication introduced in the Philippines in 2015. This was initially approved as an adjunctive treatment for focal seizures and those with secondary generalization among individuals 12  years old and above. By March 2020, it has been approved also for generalized seizures and in children 4 years and above. The general objective of this research is to describe the clinical experience of Filipino child neurologists on the use of perampanel in children.
Source: Brain and Development - Category: Neurology Authors: Tags: Original article Source Type: research